-
Bank Ranking
Banks Ratios
Cement Statistics
Cement Ranking
Cement Ratios
Monetary and Economic Statistics
Oil, Gas and Fuel
Macro Economy
Consumer Spending
Inflation
Exports & Imports
Food Prices
Non Food Prices
Construction Materials
Petrochem. Ranking
Petrochem. Ratios
Retail Rankings
Retail Ratios
Grocery Ranking
Grocery Ratios
Top Growth
Dividend History
Al-Modawat 2023 profit jumps 80% to SAR 18.6M
31/03/2024
Argaam Exclusive
Al-Modawat Specialized Medical Co.’s net profit leapt 80% to SAR 18.6 million in 2023, from SAR 10.3 million a year earlier.
Financials (M)
| Item | 2022 | 2023 | Change |
|---|---|---|---|
| Revenues | 58.57 | 74.31 | 26.9 % |
| Gross Income | 28.52 | 40.63 | 42.5 % |
| Operating Income | 11.44 | 20.17 | 76.3 % |
| Net Income | 10.31 | 18.59 | 80.3 % |
| Average Shares | 19.00 | 19.00 | - |
| EPS (Riyals) | 0.54 | 0.98 | 80.3 % |
The company posted higher revenues due to the opening of new departments such as neurology and the increase in the number of internists.
Current Half Annual Comparison (M)
| Item | H2 2022 | H2 2023 | Change |
|---|---|---|---|
| Revenues | 33.26 | 37.13 | 11.6 % |
| Gross Income | 16.61 | 19.23 | 15.8 % |
| Operating Income | 7.40 | 8.65 | 17.0 % |
| Net Income | 6.67 | 7.66 | 14.8 % |
| Average Shares | 19.00 | 19.00 | - |
| EPS (Riyals) | 0.35 | 0.40 | 14.8 % |
Total shareholders’ equity, no minority interest, stood at SAR 39.25 million by the end of 2023, compared to SAR 30.98 million a year before.
|
Historical Data |
|||
|
Period |
Revenues (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
|
H1 2022 |
25.30 |
3.64 |
1.92 |
|
H2 2022 |
33.27 |
6.67 |
3.51 |
|
H1 2023 |
37.18 |
10.93 |
5.75 |
|
H2 2023 |
37.13 |
7.66 |
4.03 |
View other reports
Share Price
Al-Modawat Specialized Medical Co. (ALMODAWAT)
| Current | |
| Market Cap (M Riyal) | 376.20 |
| Enterprise Value (EV) (M) | 382.34 |
| Shares Outstanding ((M)) | 23.75 |
| Book Value (BV) ( Riyal) | 2.07 |
| Par Value ( Riyal) | 1.00 |
| Adjusted P/E (Last12) | 20.23 |
| Price/book | 9.58 |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| H1 2023 | 37.18 | 46.9 % | 21.40 | 79.8 % | 11.52 | 184.6 % |
| H2 2023 | 37.13 | 11.6 % | 19.23 | 15.8 % | 8.65 | 17.0 % |
| 2023 | 74.31 | 26.9 % | 40.63 | 42.5 % | 20.17 | 76.3 % |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
|---|---|---|---|---|---|---|
| H1 2023 | 10.93 | 200.4 % | 0.58 | - | 10.93 | 0.58 |
| H2 2023 | 7.66 | 14.8 % | 0.40 | - | 7.66 | 0.40 |
| 2023 | 18.59 | 80.3 % | 0.98 | - | 18.59 | 0.98 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| H1 2023 | 53.96 % | 30.58 % | 25.00 % |
| H2 2023 | 54.67 % | 29.50 % | 25.02 % |
| 2023 | 54.68 % | 29.50 % | 25.02 % |
Compared With The
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| H1 2023 | 19.00 | 0.93 | 0.93 | 1.95 |
| H2 2023 | 19.00 | 0.98 | 0.98 | 2.07 |
Multiple Ratios (End of Period Price)
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| H1 2023 | - | - | - |
| H2 2023 | - | - | - |
Business Segments (Million)
Q4 2023
| Period | Medical Services | Pharmaceutical Products |
|---|---|---|
| Q2 2023 | 35.50 | 1.67 |
| Q4 2023 | 35.40 | 1.73 |
Follow us on
Call Request
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}